All News #Library
Biotech
Idorsia Launches Oral First-In-Class CCR6 Antagonist Trial
06 Jan 2026 //
GLOBENEWSWIRE
Idorsia`s Insomnia Treatment Wins Prix Galien Bridges Award
09 Dec 2025 //
GLOBENEWSWIRE
Idorsia Launches TRYVIO: First FDA-Approved Endothelin Pathway
28 Aug 2025 //
GLOBENEWSWIRE
Idorsia`s lab-made glycan vaccine platform validated in humans
30 Jun 2025 //
GLOBENEWSWIRE
Idorsia publishes positive data on daridorexant in insomnia
14 Mar 2025 //
GLOBENEWSWIRE
Idorsia teases Tryvio licensing deal while planning 270 layoffs
27 Nov 2024 //
FIERCE BIOTECH
Idorsia’s Jean-Paul Clozel retires as CEO; CRISPR nabs CMO from Sanofi
24 May 2024 //
ENDPTS
Idorsia issues invitation to the 2023 Annual General Meeting of Shareholders
06 Apr 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support